CIRM lures biotechs with $20M for stem cell teams

California's Institute of Regenerative medicine is planning to provide $20 million to each of 10 to 12 research teams that can be in the clinic with a new therapy inside of four years. Agency president Alan Trounson says that it's time to start moving stem cell work out of the lab and into human trials. Report